Changes in nervous system glycolipids during metamorphosis of Xenopus laevis.
Qualitative and quantitative changes occurring in the myelin marker glycolipids, cerebrosides, sulfatides, and monogalactosyl diglyceride, in the nervous system (brain, spinal cord, and tail) of Xenopus laevis during its metamorphic stages were analyzed by normal and reverse-phase high performance liquid chromatography. The concentration of these glycolipids increased rapidly in brain until the tadpole reached the middle of metamorphosis, fluctuated slightly, decreased until metamorphosis was completed, and increased once more as the frog matured. Similar changes were observed in the spinal cord, but the decrease of glycolipids occurred at a later stage of metamorphosis. The glycolipid level in tail nerve reached a peak at the beginning of metamorphosis and then rapidly decreased. The ratios of hydroxycerebroside and hydroxysulfatide to respective nonhydroxylipids in brain, spinal cord, and tail remained constant throughout the metamorphic change but differed in each tissue. The tail contained the highest ratio. The glycolipids in sciatic nerve generated during the metamorphosis had an even higher hydroxyl lipid/nonhydroxy lipid ratio. The cerebrosides contained extremely high concentrations of monounsaturated fatty acids with very long carbon chains (C22-C25) and this homolog composition remained almost unchanged throughout metamorphosis. These results indicate that active degradation of these glycolipids, and probably of myelin, occurs but the glycolipid composition of myelin appears to remain the same throughout the metamorphic process. The significance of these findings is discussed from a morphological standpoint.
D000818:Animals; D001921:Brain / Q000254:growth & development* / Q000378:metabolism; D002554:Cerebrosides / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D004075:Diglycerides / Q000378:metabolism*; D038983:Galactolipids; D005989:Glycerides / Q000378:metabolism*; D006017:Glycolipids / Q000302:isolation & purification / Q000378:metabolism*; D008675:Metamorphosis, Biological; D009186:Myelin Sheath / Q000378:metabolism*; D013116:Spinal Cord / Q000254:growth & development* / Q000378:metabolism; D013433:Sulfoglycosphingolipids / Q000378:metabolism*; D014981:Xenopus / Q000254:growth & development*
D002554:Cerebrosides; D004075:Diglycerides; D038983:Galactolipids; D005989:Glycerides; D006017:Glycolipids; D013433:Sulfoglycosphingolipids; C009909:monogalactosyldiacylglycerol